Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament

摘要

The invention relates to medicaments which contain one or more compounds inhibiting the biological effects of TNF-alpha and CD95L, e.g. by blocking the binding of these ligands to their natural receptors thus eliminating signal transduction. These compounds are preferably a neutralizing anti-TNF-alpha antibody and a neutralizing anti-CD95L antibody. The invention also relates to the use of the above compounds for preventing or treating an apoplectic stroke or heart attack.